Studies on the Effect of Lipofectamine and Cell-Penetrating Peptide on the Properties of 10-23 DNAzyme

被引:2
作者
Liu, Huanhuan [1 ,2 ]
Li, Yang [2 ]
Du, Shanshan [2 ]
Wang, Chenhong [2 ]
Li, Yuexiang [2 ]
Cao, Ruiyuan [2 ]
Shi, Weiguo [2 ]
Liu, Shihui [1 ]
He, Junlin [2 ]
机构
[1] Guizhou Univ, Sch Pharmaceut Sci, Guiyang 550025, Peoples R China
[2] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasurements, Taiping 27, Beijing 100850, Peoples R China
基金
中国国家自然科学基金;
关键词
10-23; DNAzyme; cell-penetrating peptide; lipofectamine; 2000; observed rate constant; T-m; CD spetra; PAGE analysis; DEOXYRIBOZYME ACTIVITY; IN-VIVO; DELIVERY; OLIGONUCLEOTIDES; NANOPARTICLES; ENHANCEMENT; THERAPY;
D O I
10.3390/molecules28093942
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cationic polymeric materials and cell-penetrating peptides (CPPs) were often used as the delivery vectors in the evaluation of nucleic acid therapeutics. 10-23 DNAzyme is a kind of potential antisense therapeutics by catalytic cleavage of the disease-related RNAs. Here, lipofectamine 2000 and Tat peptide were evaluated for their effect on the catalytic activity of 10-23 DNAzyme, with the observed rate constant, thermal stability, CD spectra, and PAGE analysis, with a duplex DNA mimicking DNAzyme-substrate as a control. It was shown that the cationic carriers had a negative effect on the catalytic performance of the 10-23 DNAzyme. Significantly, the destabilizing effect of the cationic carriers on the duplex formation was noteworthy, as a duplex formation is an essential prerequisite in the silencing mechanisms of antisense and RNAi.
引用
收藏
页数:9
相关论文
共 39 条
[1]   Therapeutic Antisense Oligonucleotides Are Coming of Age [J].
Bennett, C. Frank .
ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 :307-321
[2]   Delivery of therapeutic oligonucleotides with cell penetrating peptides [J].
Boisguerin, Prisca ;
Deshayes, Sebastien ;
Gait, Michael J. ;
O'Donovan, Liz ;
Godfrey, Caroline ;
Betts, Corinne A. ;
Wood, Matthew J. A. ;
Lebleu, Bernard .
ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 :52-67
[3]   Melanoma protective antitumor immunity activated by catalytic DNA [J].
Cai, Hong ;
Cho, Eun-Ae ;
Li, Yue ;
Sockler, Jim ;
Parish, Christopher R. ;
Chong, Beng H. ;
Edwards, Jarem ;
Dodds, Tristan J. ;
Ferguson, Peter M. ;
Wilmott, James S. ;
Scolyer, Richard A. ;
Halliday, Gary M. ;
Khachigian, Levon M. .
ONCOGENE, 2018, 37 (37) :5115-5126
[4]   Biostable L-DNAzyme for Sensing of Metal Ions in Biological Systems [J].
Cui, Liang ;
Peng, Ruizi ;
Fu, Ting ;
Zhang, Xiaobing ;
Wu, Cuichen ;
Chen, Huapei ;
Liang, Hao ;
Yang, Chaoyong James ;
Tan, Weihong .
ANALYTICAL CHEMISTRY, 2016, 88 (03) :1850-1855
[5]   Synthetic Nucleic Acid Delivery Systems: Present and Perspectives [J].
Draghici, Bogdan ;
Ilies, Marc A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (10) :4091-4130
[6]   Re-Engineering RNA Molecules into Therapeutic Agents [J].
Egli, Martin ;
Manoharan, Muthiah .
ACCOUNTS OF CHEMICAL RESEARCH, 2019, 52 (04) :1036-1047
[7]   DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes [J].
Fokina, Alesya A. ;
Stetsenko, Dmitry A. ;
Francois, Jean-Christophe .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (05) :689-711
[8]   MNAzyme-catalyzed nucleic acid detection enhanced by a cationic copolymer [J].
Gao, Jueyuan ;
Shimada, Naohiko ;
Maruyama, Atsushi .
BIOMATERIALS SCIENCE, 2015, 3 (05) :716-720
[9]   Science Enhancement of deoxyribozyme activity by cationic copolymers [J].
Gao, Jueyuan ;
Shimada, Naohiko ;
Maruyama, Atsushi .
BIOMATERIALS SCIENCE, 2015, 3 (02) :308-316
[10]   A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial [J].
Greulich, Timm ;
Hohlfeld, Jens M. ;
Neuser, Petra ;
Lueer, Katrin ;
Klemmer, Andreas ;
Schade-Brittinger, Carmen ;
Harnisch, Susanne ;
Garn, Holger ;
Renz, Harald ;
Homburg, Ursula ;
Renz, Jonas ;
Kirsten, Anne ;
Pedersen, Frauke ;
Mueller, Meike ;
Vogelmeier, Claus F. ;
Watz, Henrik .
RESPIRATORY RESEARCH, 2018, 19